Checkpoint Therapeutics Announces Confirmation of Registration Path for Cosibelimab in Metastatic Cutaneous Squamous Cell Carcinoma
Journey Medical Corporation Recaps 2019 Growth
Fortress Biotech Announces Exclusive Worldwide License Agreement With AstraZeneca and Cincinnati Children’s Hospital Medical Center to Develop a Novel Treatment for Select CNS Disorders
12th Annual LD Micro Main Event Investor Conference
Stay informed and receive company updates straight to your inbox.